Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010.
about
Beta-blockers for prevention and treatment of retinopathy of prematurity in preterm infantsTeleophthalmology: improving patient outcomes?Intrapartum-related neonatal encephalopathy incidence and impairment at regional and global levels for 2010 with trends from 1990.Count every newborn; a measurement improvement roadmap for coverage data.Estimates of neonatal morbidities and disabilities at regional and global levels for 2010: introduction, methods overview, and relevant findings from the Global Burden of Disease study.Inpatient care of small and sick newborns: a multi-country analysis of health system bottlenecks and potential solutionsTraining retinal imagers for retinopathy of prematurity (ROP) screeningRetinopathy of prematurity blindness worldwide: phenotypes in the third epidemicFrequency of retinopathy of prematurity in premature neonates with a birth weight below 1500 grams and a gestational age less than 32 weeks: a study from a tertiary care hospital in a lower-middle income country….Retinopathy of prematurity risk prediction for infants with birth weight less than 1251 grams.Time at treatment of severe retinopathy of prematurity in China: recommendations for guidelines in more mature infants.Case series of infants presenting with end stage retinopathy of prematurity to two tertiary eye care facilities in Mexico: underlying reasons for late presentation.Visual impairment due to retinopathy of prematurity (ROP) in New Zealand: a 22-year review.Retinopathy of prematurity: New developments bring concern and hope.Safety of Retinopathy of Prematurity Examination and Imaging in Premature Infants.Effect of Preterm Birth on Postnatal Apolipoprotein and Adipocytokine ProfilesLevel of mortality risk for babies born preterm or with a small weight for gestation in a tertiary hospital of Nepal.A Comparison of Strategies for Retinopathy of Prematurity DetectionRisk of recurrence of retinopathy of prematurity after initial intravitreal ranibizumab therapy.Treatment of type I ROP with intravitreal bevacizumab or laser photocoagulation according to retinal zone.Incidence of retinopathy of prematurity at two tertiary centers in Jeddah, Saudi Arabia.Fzd4 Haploinsufficiency Delays Retinal Revascularization in the Mouse Model of Oxygen Induced RetinopathyCombination of Intravitreal Injection of Ranibizumab and Photocoagulation for the Treatment of Aggressive Posterior Retinopathy of Prematurity with Vitreous Hemorrhage.Retinopathy of prematurity in Indonesia: Incidence and risk factors.Treatment trends for retinopathy of prematurity in the UK: active surveillance study of infants at risk.Association of maternal hypertensive disorders with retinopathy of prematurity: A systematic review and meta-analysisBim expression in endothelial cells and pericytes is essential for regression of the fetal ocular vasculature.Potential for a paradigm change in the detection of retinopathy of prematurity requiring treatmentMurine model: maternal administration of stem cells for prevention of prematurity.Preterm birth-associated neurodevelopmental impairment estimates at regional and global levels for 2010.Safety and pharmacokinetics of multiple dose myo-inositol in preterm infants.Impact of retinopathy of prematurity on ocular structures and visual functions.Study protocol: safety and efficacy of propranolol 0.2% eye drops in newborns with a precocious stage of retinopathy of prematurity (DROP-ROP-0.2%): a multicenter, open-label, single arm, phase II trial.Long-term neurodevelopmental outcome in high-risk newborns in resource-limited settings: a systematic review of the literature.Impact of expansion of telemedicine screening for retinopathy of prematurity in India.Clinical Management of Recurrent Retinopathy of Prematurity after Intravitreal Bevacizumab Monotherapy.Review of the mechanisms and therapeutic avenues for retinal and choroidal vascular dysfunctions in retinopathy of prematurity.Aggressive posterior retinopathy of prematurity: a pilot study of quantitative analysis of vascular features.The omega-3 and retinopathy of prematurity relationshipDevelopment and verification of a pharmacokinetic model to optimize physiologic replacement of rhIGF-1/rhIGFBP-3 in preterm infants.
P2860
Q24187442-28C3E617-E664-41B9-9A0F-F38F34EC50C8Q26765328-818CA2D0-59FD-4743-99A6-24AA1643AD85Q27000167-D44B4E65-38CC-4F07-B8D3-0A9C7266DA88Q30387582-6816D503-BF3F-406D-B247-1857FB058573Q30392619-C6DD03A7-41F6-4A53-BF81-DF38DC73AD1EQ30665094-65079E6D-F336-4531-961C-93A70FA77921Q30781972-6CC1BFDE-94BA-406E-B383-3E40CFCAB655Q33585456-ED434FF0-C0A4-43EA-8620-1E1CB8C51BA2Q33837942-0A198AF9-E324-470C-A101-274FD48A6992Q35020037-E40D1582-EC92-4B1D-B529-60B449CC7487Q35064631-A7FA547F-BC58-4DBA-AF46-B1391E132972Q35468961-9CFF180E-4291-4E5E-A0BF-38C93CDF3255Q35531405-E5197FE9-E21C-45EE-A543-039AB72F7C67Q35574624-FCA19CDA-53C7-4BAD-8156-0AC51D63DAA4Q35753169-386B36CD-1C4C-41C3-998F-BEBD891D5C4CQ35762978-D84551C9-A5AB-4533-8B1E-8D4F5FEE72C3Q35770229-462F5C6E-AA9E-42F5-925D-6CD4953DAD08Q35869916-390051D6-D8AD-466A-838E-C4331EAFDEFFQ36039050-16A33BF0-C930-41D6-8641-A8258089BB86Q36052210-5D6CF2F3-37D2-42C7-9AC7-53690A299E80Q36058504-43BD3113-EADC-41C1-8AC7-18793C112588Q36094613-2F98D1DC-6440-44A8-9BAF-E466F30DE1D5Q36245132-3873C4B3-91BD-4C40-AD1F-AAA8B0FC6C31Q36311820-14968A4B-6C78-4719-AB87-3D3D6F413EBBQ36317010-AC48EBC5-5037-4337-A79A-3C8812905865Q36339840-0F5F870F-0FD8-48C8-8232-D111E1A8A7A5Q36383866-AB56898F-A257-4E84-AB2B-6C489716C9E1Q36475584-665E28EB-0496-433E-AEEC-3AC35893D6C5Q36755365-3C473D87-2616-4E3A-A885-FF83B8C38374Q37416047-8AF7105C-0463-4639-A8D9-A51C744226C3Q37544118-4C6483C5-9A48-4597-B1A8-98AD05C7DBE0Q38261899-8041FE9E-078A-44F6-8DEB-B24222C7C70EQ38373964-EA67456D-8F47-4796-A690-084EBDCEA87DQ38542165-2827B4CC-DCDE-4273-A01F-8620BE286D71Q38749189-EF6EB064-4E76-4703-A232-08009C1F7ECEQ38848653-2D993502-2920-4DD8-A1C8-7CCA7D25DBE4Q38952692-9D34A767-6B4C-41A0-8945-E01909CB84B5Q39095653-EF4256D8-50F4-4DD0-AE90-72FADC03C1D3Q39157315-5986A6F5-9330-4160-8FAC-86B9C5FB4FBDQ39167922-990C0F85-68E9-4D3D-8AC6-C30F24CA1B64
P2860
Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Preterm-associated visual impa ...... al and global levels for 2010.
@en
Preterm-associated visual impa ...... al and global levels for 2010.
@nl
type
label
Preterm-associated visual impa ...... al and global levels for 2010.
@en
Preterm-associated visual impa ...... al and global levels for 2010.
@nl
prefLabel
Preterm-associated visual impa ...... al and global levels for 2010.
@en
Preterm-associated visual impa ...... al and global levels for 2010.
@nl
P2093
P2860
P31
P921
P356
P1433
P1476
Preterm-associated visual impa ...... al and global levels for 2010.
@en
P2093
Alistair Fielder
Clare Gilbert
Thomas Vazquez
P2860
P2888
P356
10.1038/PR.2013.205
P407
P478
74 Suppl 1
P5008
P577
2013-12-01T00:00:00Z